142 related articles for article (PubMed ID: 7728779)
21. Antibody responses to HPV16 virus-like particles in women with cervical intraepithelial neoplasia infected with a variant HPV16.
Ellis JR; Etherington I; Galloway D; Luesley D; Young LS
Lancet; 1997 Apr; 349(9058):1069-70. PubMed ID: 9107250
[No Abstract] [Full Text] [Related]
22. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.
Combita AL; Bravo MM; Touzé A; Orozco O; Coursaget P
Int J Cancer; 2002 Feb; 97(6):796-803. PubMed ID: 11857357
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer.
Meschede W; Zumbach K; Braspenning J; Scheffner M; Benitez-Bribiesca L; Luande J; Gissmann L; Pawlita M
J Clin Microbiol; 1998 Feb; 36(2):475-80. PubMed ID: 9466762
[TBL] [Abstract][Full Text] [Related]
24. Antibodies prevalence against HPV-6b and -16 recombinant fusion proteins in Korean patients with cervical neoplasia.
Park SN; Yoon HS; Choi YK; Choe IS; Chung RP; Chee YH; Namkoong SE; Kim SJ; Park JS
J Obstet Gynaecol (Tokyo 1995); 1995 Dec; 21(6):609-17. PubMed ID: 8640473
[TBL] [Abstract][Full Text] [Related]
25. Characterization of IgA response among women with incident HPV 16 infection.
Onda T; Carter JJ; Koutsky LA; Hughes JP; Lee SK; Kuypers J; Kiviat N; Galloway DA
Virology; 2003 Jul; 312(1):213-21. PubMed ID: 12890634
[TBL] [Abstract][Full Text] [Related]
26. Immunity to oncogenic human papillomaviruses.
Konya J; Dillner J
Adv Cancer Res; 2001; 82():205-38. PubMed ID: 11447764
[TBL] [Abstract][Full Text] [Related]
27. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ
J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287
[TBL] [Abstract][Full Text] [Related]
28. Seric and local antibodies against a synthetic peptide of HPV16.
Dreyfus M; Baldauf JJ; Ritter J; Obert G
Eur J Obstet Gynecol Reprod Biol; 1995 Apr; 59(2):187-91. PubMed ID: 7657014
[TBL] [Abstract][Full Text] [Related]
29. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
Marais D; Rose RC; Williamson AL
J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543
[TBL] [Abstract][Full Text] [Related]
30. Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection.
Wikström A; van Doornum GJ; Kirnbauer R; Quint WG; Dillner J
J Med Virol; 1995 Aug; 46(4):368-74. PubMed ID: 7595415
[TBL] [Abstract][Full Text] [Related]
31. T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection.
de Gruijl TD; Bontkes HJ; Stukart MJ; Walboomers JM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2183-91. PubMed ID: 8811018
[TBL] [Abstract][Full Text] [Related]
32. Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia.
Rocha-Zavaleta L; Jordan D; Pepper S; Corbitt G; Clarke F; Maitland NJ; Sanders CM; Arrand JR; Stern PL; Stacey SN
Br J Cancer; 1997; 75(8):1144-50. PubMed ID: 9099962
[TBL] [Abstract][Full Text] [Related]
33. Association of serum antibodies against defined epitopes of human papillomavirus L1, E2, and E7 antigens and of HPV DNA with incident cervical cancer.
Dillner L; Zellbi A; Avall-Lundqvist E; Heino P; Eklund C; Pettersson CA; Forslund O; Hansson BG; Grandien M; Bistoletti P
Cancer Detect Prev; 1995; 19(5):381-93. PubMed ID: 7585724
[TBL] [Abstract][Full Text] [Related]
34. The use of vaccines in the prevention and treatment of cervical cancer.
Davidson EJ; Kitchener HC; Stern PL
Clin Oncol (R Coll Radiol); 2002 Jun; 14(3):193-200. PubMed ID: 12109821
[TBL] [Abstract][Full Text] [Related]
35. Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study.
de Gruijl TD; Bontkes HJ; Walboomers JM; Stukart MJ; Robbesom AA; von Blomberg-van der Flier BM; Herbrink P; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
Int J Cancer; 1996 Dec; 68(6):731-8. PubMed ID: 8980175
[TBL] [Abstract][Full Text] [Related]
36. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
Matsumoto K; Yoshikawa H; Yasugi T; Nakagawa S; Kawana K; Takeoka A; Yaegashi N; Iwasaka T; Kanazawa K; Taketani Y; Kanda T
J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056
[TBL] [Abstract][Full Text] [Related]
37. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.
Carter JJ; Koutsky LA; Hughes JP; Lee SK; Kuypers J; Kiviat N; Galloway DA
J Infect Dis; 2000 Jun; 181(6):1911-9. PubMed ID: 10837170
[TBL] [Abstract][Full Text] [Related]
38. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide.
Kadish AS; Timmins P; Wang Y; Ho GY; Burk RD; Ketz J; He W; Romney SL; Johnson A; Angeletti R; Abadi M;
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):483-8. PubMed ID: 12010863
[TBL] [Abstract][Full Text] [Related]
39. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
Heim K; Christensen ND; Höpfl R; Wartusch B; Zeimet A; Larcher C; Ruth N; Bergant A; Pirschner G; Dierich MP
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():25-31. PubMed ID: 8672922
[TBL] [Abstract][Full Text] [Related]
40. Cervical cancer, human papillomavirus and vaccines.
Khan SA
Clin Oncol (R Coll Radiol); 1993; 5(6):386-90. PubMed ID: 8305362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
